Healthcare stocks are gaining momentum as the Centers for Medicare & Medicaid Services signaled higher Medicare Advantage payment rates for 2027. The prospect of increased reimbursements is boosting profit outlooks for managed‑care providers, with CVS Health rallying 4.5% after the surprise news. Analysts view the sector’s valuation as compelling, offering both value and rapid earnings growth potential. The broader market is watching these developments as a catalyst for the industry.

The article argues that healthcare revenue‑cycle partners must shift from reactive "tell us what you need" approaches to proactive, anticipatory support. Operators juggling access, staffing, patient experience, and finances often lack the bandwidth to articulate needs during crises. By identifying...
PharmaForce has named Lynn Eschenbacher, PharmD, MBA, FASHP, as its new Chief Pharmacy and Strategy Officer to steer the company’s 340B program strategy. Eschenbacher brings over 25 years of pharmacy leadership across major health systems, most recently at Quva Pharma. The...

Medication non‑adherence still costs U.S. drug makers roughly $250 billion a year, despite billions spent on marketing. Independent pharmacies, which patients visit nearly twice as often as primary‑care doctors, are emerging as a critical touchpoint as chain stores close. New pharmacy‑focused...
Humira, AbbVie’s adalimumab used by over 300,000 Americans, continues to dominate the market even after its patent expired, keeping prices sky‑high. The drug’s outsized share illustrates systemic flaws in U.S. pharmaceutical distribution, where limited biosimilar competition and opaque pricing inflate...

Digital health tools have long suffered from gender bias because training data and clinical trials underrepresent women. The Consumer Technology Association (CTA) has introduced the first ANSI‑accredited women’s health standard, giving developers a concrete framework for inclusive design, testing, and...

Weight‑loss drugs targeting the GLP‑1 pathway are reshaping consumer demand for smaller, nutrient‑dense portions, prompting food manufacturers to explore “GLP‑1 friendly” labeling. In the EU, such phrasing is classified as a health claim and, without an approved application, is unlikely...
A 2026 study of 110 AIDS patients identified low body mass index, low CD4⁺ T‑lymphocyte count, and low serum albumin as independent nutritional risk factors. Using these three routinely measured variables, the authors built a nomogram that achieved an area...
A prospective study of 603 ICU patients found that bedside measurements of quadriceps muscle – both circumference and ultrasound thickness – independently predict 28‑day mortality. Higher quadriceps circumference (QC) and greater ultrasound‑derived thickness under minimal (QT‑min) and maximal (QT‑max) transducer...

Silo Pharma’s shares surged 51.8% to $0.54 in pre‑market trading after the European Patent Office issued a Rule 71(3) communication indicating a likely grant of a patent for its novel 5‑HT4 receptor preventative therapy. The announcement sparked a broader pre‑market rally...

Dental billing software and AI tools have streamlined routine claim processing, but they fall short on complex cases that require nuanced judgment. Human specialists can interpret carrier‑specific rules, craft targeted appeals, and detect systemic denial patterns that automation misses. Over‑reliance...

Sanofi announced that its bispecific Nanobody lunsekimig achieved both primary and key secondary endpoints in the phase 2b AIRCULES asthma trial and the phase 2a DUET study for chronic rhinosinusitis with nasal polyps (CRSwNP). The asthma study showed a statistically...
ImmunityBio (NASDAQ: IBRX) saw its stock dip after the FDA sent a warning letter accusing the company of false or misleading promotion of its bladder‑cancer drug Anktiva. The regulator flagged a TV advertisement and a provocative podcast episode, prompting ImmunityBio...

Scientists from the University of Concepción and the University of Maryland identified a previously unknown appetite‑regulating circuit in the hypothalamus. The study, published in PNAS on April 6, 2026, shows that tanycytes release lactate, which activates astrocytic HCAR1 receptors, prompting glutamate release...

The Centers for Medicare & Medicaid Services opened applications for its new Long‑Term Enhanced ACO Design (LEAD) model, with a May 17 deadline and a Jan 1 2027 start date. LEAD replaces the outgoing ACO REACH program and promises broader inclusion of high‑needs...